Chloroquine engages the immune system to eradicate irradiated breast tumors in mice

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 4, 2013, Pages 761-768

  Ratikan, Josephine Anna ^a   Sayre, James William ^a   Schaue, Dörthe ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMOR ACTIVITIES; ANTITUMOR IMMUNITY; CANCER THERAPY; DENDRITIC CELLS; IMMUNE RESPONSE; METHODS AND MATERIALS; RADIATION-INDUCED; TUMOR VACCINES;

CELL DEATH; CURING; DISEASES; IMMUNE SYSTEM; MAMMALS; T-CELLS; TUMORS;

RADIOTHERAPY;

ANTIGEN; CANCER VACCINE; CHLOROQUINE; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER THERAPY; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; CROSS PRESENTATION; DEGRADATION KINETICS; DENDRITIC CELL; ENDOSOME; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROQUINE; COMBINED MODALITY THERAPY; DENDRITIC CELLS; ENDOSOMES; FEMALE; IMMUNOTHERAPY, ACTIVE; MICE; MICE, INBRED C3H; OVALBUMIN;

EID: 84886069176     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.07.024     Document Type: Article

References (20)

1. J. Sotelo, E. Briceno, and M.A. Lopez-Gonzalez Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial Ann Intern Med 144 2006 337 343
2. S.H. Kim, J.H. Kim, and J. Fried Enhancement of the radiation response of cultured tumor cells by chloroquine Cancer 32 1973 536 540
3. K.H. Maclean, F.C. Dorsey, and J.L. Cleveland Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis J Clin Invest 118 2008 79 88
4. R.K. Amaravadi, D. Yu, and J.J. Lum Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma J Clin Invest 117 2007 326 336
5. X. Liang, M.E. De Vera, and W.J. Buchser Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression Cancer Res 72 2012 2791 2801
6. L. Apetoh, F. Ghiringhelli, and A. Tesniere Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nat Med 13 2007 1050 1059
7. A. Pollack, N.H. Terry, and R.A. White Proliferation kinetics of recruited cells in a mouse mammary carcinoma Cancer Res 54 1994 811 817
8. Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83:1306-1310.
9. L.E. Moses A two-sample test Psychometrika 17 1952 239 247
10. A. Apel, I. Herr, and H. Schwarz Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy Cancer Res 68 2008 1485 1494
11. S. Periyasamy-Thandavan, M. Jiang, and P. Schoenlein Autophagy: molecular machinery, regulation, and implications for renal pathophysiology Am J Physiol Renal Physiol 297 2009 F244 F256
12. Z. Yang, and D.J. Klionsky An overview of the molecular mechanism of autophagy Curr Top Microbiol Immunol 335 2009 1 32
13. C. Munz Enhancing immunity through autophagy Annu Rev Immunol 27 2009 423 449
14. D. Schaue, B. Comin-Anduix, and A. Ribas T-cell responses to survivin in cancer patients undergoing radiation therapy Clin Cancer Res 14 2008 4883 4890
15. Y.H. Yoon, K.S. Cho, and J.J. Hwang Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells Invest Ophthalmol Vis Sci 51 2010 6030 6037
16. D. Accapezzato, V. Visco, and V. Francavilla Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo J Exp Med 202 2005 817 828
17. C.G. Twitty, S.M. Jensen, and H.M. Hu Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism Clin Cancer Res 17 2011 6467 6481
18. Z. Shen, G. Reznikoff, and G. Dranoff Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules J Immunol 158 1997 2723 2730
19. S. Burgdorf, C. Scholz, and A. Kautz Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation Nat Immunol 9 2008 558 566
20. M. Gannage, and C. Munz Autophagy in MHC class II presentation of endogenous antigens Curr Top Microbiol Immunol 335 2009 123 140